{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:20:54Z","timestamp":1791580854054,"version":"4.3.4"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1093\/brain\/awn291","type":"journal-article","created":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T01:13:27Z","timestamp":1227575607000},"page":"156-171","source":"Crossref","is-referenced-by-count":288,"title":["Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study"],"prefix":"10.1093","volume":"132","author":[{"given":"Gilbert","family":"Bensimon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Agid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vidailhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Payan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Nigel","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,11,23]]},"reference":[{"key":"key\n\t\t\t\t20170508032627_B1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0166-2236(00)01794-X","article-title":"New insights into progressive supranuclear palsy","volume":"24","author":"Albers","year":"2001","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t20170508032627_B2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.42.4.733","article-title":"Alternative excitotoxic hypotheses","volume":"42","author":"Albin","year":"1992","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B3","volume-title":"Survival Analysis using the SAS System \u2013 A Practical Guide","author":"Allison","year":"1995"},{"key":"key\n\t\t\t\t20170508032627_B4","volume-title":"Standard for educational and psychological testing","author":"American Psychological Association","year":"1985"},{"key":"key\n\t\t\t\t20170508032627_B5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.18773\/austprescr.2003.082","article-title":"Moving beyond sensitivity and specificity: Using likelihood ratios to help interpret diagnostic tests","volume":"26","author":"Attia","year":"2003","journal-title":"Australian Prescriber"},{"key":"key\n\t\t\t\t20170508032627_B6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","article-title":"Survival of patients with pathologically proven multiple system atrophy: a meta-analysis","volume":"48","author":"Ben-Shlomo","year":"1997","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s004150200071","article-title":"A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis","volume":"249","author":"Bensimon","year":"2002","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170508032627_B8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508032627_B9","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/mds.21052","article-title":"Olivopontocerebellar atrophy: toward a better nosological definition","volume":"21","author":"Berciano","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B10","volume-title":"Discrete multivariate analysis: theory and practice","author":"Bishop","year":"1975"},{"key":"key\n\t\t\t\t20170508032627_B11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mds.20802","article-title":"Cognitive function in multiple system atrophy of the cerebellar type","volume":"21","author":"Burk","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1474-4422(02)00161-8","article-title":"Progressive supranuclear palsy: where are we now?","volume":"1","author":"Burn","year":"2002","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170508032627_B14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-4159.2006.03711.x","article-title":"Specific regulation of rat glial cell line-derived neurotrophic factor gene expression by riluzole in C6 glioma cells","volume":"97","author":"Caumont","year":"2006","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170508032627_B15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"B34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"key\n\t\t\t\t20170508032627_B16","doi-asserted-by":"crossref","first-page":"II6","DOI":"10.1007\/BF03161076","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"Dickson","year":"1999","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170508032627_B17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170508032627_B18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00702-004-0206-z","article-title":"Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice","volume":"112","author":"Diguet","year":"2005","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170508032627_B19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20170508032627_B20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"key\n\t\t\t\t20170508032627_B21","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00702-005-0328-y","article-title":"The European Multiple System Atrophy-Study Group (EMSA-SG)","volume":"112","author":"Geser","year":"2005","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170508032627_B22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.20678","article-title":"Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)","volume":"21","author":"Geser","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.55.4.527","article-title":"Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy","volume":"55","author":"Gilman","year":"2000","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology","volume":"8","author":"Gilman","year":"1998","journal-title":"Clin Auton Res"},{"key":"key\n\t\t\t\t20170508032627_B25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.46.5.1197","article-title":"The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy","volume":"46","author":"Gilman","year":"1996","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.38.7.1031","article-title":"Prevalence and natural history of progressive supranuclear palsy","volume":"38","author":"Golbe","year":"1988","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B27","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B28","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B29","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1073\/pnas.182426599","article-title":"Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay","volume":"99","author":"Heiser","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170508032627_B30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170508032627_B32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ana.21181","article-title":"Riluzole in Huntington's disease: a 3-year, randomized controlled study","volume":"62","author":"Landwehrmeyer","year":"2007","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508032627_B33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jnnp.57.2.129","article-title":"Cellular pathology of multiple system atrophy: a review","volume":"57","author":"Lantos","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170508032627_B34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/mds.10562","article-title":"Update on epidemiological aspects of progressive supranuclear palsy","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.46.4.922","article-title":"Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)","volume":"46","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","article-title":"Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","article-title":"What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study","volume":"54","author":"Litvan","year":"1997","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170508032627_B39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","article-title":"Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders","volume":"55","author":"Litvan","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508032627_B40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/089198879801100208","article-title":"Clinical and genetic aspects of progressive supranuclear palsy","volume":"11","author":"Litvan","year":"1998","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"key\n\t\t\t\t20170508032627_B41","first-page":"341","article-title":"Progressive supranuclear palsy","volume":"80","author":"Litvan","year":"1999","journal-title":"Adv Neurol"},{"key":"key\n\t\t\t\t20170508032627_B42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jnnp.60.6.615","article-title":"Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study","volume":"60","author":"Litvan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170508032627_B43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/brain\/awm328","article-title":"Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy","volume":"131","author":"Lyoo","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B44","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1958","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170508032627_B45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/NMM:3:2:65","article-title":"Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders","volume":"3","author":"Mattson","year":"2003","journal-title":"Neuromolecular Med"},{"key":"key\n\t\t\t\t20170508032627_B46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000089627","article-title":"Clinical trials in ALS: what did we learn from recent trials in humans?","volume":"2","author":"Meininger","year":"2005","journal-title":"Neurodegener Dis"},{"key":"key\n\t\t\t\t20170508032627_B47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001447.pub2","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"CD001447","author":"Miller","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170508032627_B48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-510X(99)00209-9","article-title":"Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research","volume":"169","author":"Miller","year":"1999","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170508032627_B49","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/01.WNL.0000052991.70149.68","article-title":"Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study","volume":"60","author":"Nath","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B50","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/124.7.1438","article-title":"The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK","volume":"124","author":"Nath","year":"2001","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1353-8020(00)00011-0","article-title":"The epidemiology of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)","volume":"6","author":"Nath","year":"2000","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170508032627_B52","volume-title":"Psychometric theory","author":"Nunnally","year":"1994"},{"key":"key\n\t\t\t\t20170508032627_B53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.10680","article-title":"Accuracy of clinical diagnosis of progressive supranuclear palsy","volume":"19","author":"Osaki","year":"2004","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B54","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.WNL.0000028690.15001.00","article-title":"Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?","volume":"59","author":"Osaki","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170508032627_B56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.10.012","article-title":"Pathogenesis of nigral cell death in Parkinson's disease","volume":"11","author":"Przedborski","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170508032627_B57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/115.1.271","article-title":"Cognitive performance in multiple system atrophy","volume":"115","author":"Robbins","year":"1992","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jnnp.57.1.79","article-title":"Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction","volume":"57","author":"Robbins","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170508032627_B59","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.50.6.1637","article-title":"Progressive supranuclear palsy: a survey of the disease course","volume":"50","author":"Santacruz","year":"1998","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508032627_B60","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00702-004-0245-5","article-title":"Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy)","volume":"112","author":"Scherfler","year":"2005","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170508032627_B61","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170508032627_B62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.21839","article-title":"Survival in multiple system atrophy","volume":"23","author":"Schrag","year":"2008","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508032627_B63","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1111\/j.1460-9568.2006.05218.x","article-title":"Riluzole promotes cell survival and neurite outgrowth in rat sensory neurones in vitro","volume":"24","author":"Shortland","year":"2006","journal-title":"Eur J Neurosci"},{"key":"key\n\t\t\t\t20170508032627_B64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170508032627_B65","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198528470.001.0001","volume-title":"Health Measurement Scales: a practical guide to their development and use","author":"Streiner","year":"2003"},{"key":"key\n\t\t\t\t20170508032627_B66","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00868999","article-title":"Survival in multiple system atrophy: a study of prognostic factors in 59 cases","volume":"243","author":"Testa","year":"1996","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170508032627_B67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s100720100021","article-title":"Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy","volume":"22","author":"Testa","year":"2001","journal-title":"Neurol Sci"},{"key":"key\n\t\t\t\t20170508032627_B68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s100720170065","article-title":"Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms","volume":"22","author":"Vanacore","year":"2001","journal-title":"Neurol Sci"},{"key":"key\n\t\t\t\t20170508032627_B69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s100720170064","article-title":"Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms","volume":"22","author":"Vanacore","year":"2001","journal-title":"Neurol Sci"},{"key":"key\n\t\t\t\t20170508032627_B70","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B71","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B72","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/brain\/awm104","article-title":"Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome","volume":"130","author":"Williams","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508032627_B73","first-page":"309","volume-title":"Design and analysis of factorial experiments in Statistical principles in experimental design","author":"Winer","year":"1971"},{"key":"key\n\t\t\t\t20170508032627_B74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0197-2456(88)90007-4","article-title":"Sample size for comparison of changes in the presence of right censoring caused by death, withdrawal, and staggered entry","volume":"9","author":"Wu","year":"1988","journal-title":"Control Clin Trials"},{"key":"key\n\t\t\t\t20170508032627_B75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/sim.4780070134","article-title":"Analysing changes in the presence of informative right censoring caused by death and withdrawal","volume":"7","author":"Wu","year":"1988","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170508032627_B76","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1167\/iovs.05-0376","article-title":"Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo","volume":"46","author":"Yoo","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/132\/1\/156\/16695185\/awn291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T15:34:24Z","timestamp":1738683264000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awn291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,23]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,11,23]]},"published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awn291","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11,23]]}}}